amylyx glp 1 Today, we announced the nomination of an investigational, long-acting GLP-1 receptor antagonist as our new development candidate, identified in collaboration with Gubra A/S. Learn more about this exciting update: https://t.co/yXStYTN9Kw Fat Metabolism Support Partner With Us | Amylyx
Description
The sensor continuously measures both glucose and ketones from a single wearable device
The genetic test identifies variants that influence appetite regulation and receptor sensitivitynot exact medication response
[DOI] [PubMed] [Google Scholar] 72.Bjornholm KD, et al
Shah, and K
That's all for this issue of The Refill, a LinkedIn newsletter from Pharmacy Times
